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Abstract
In the present study, we firstly assessed Cetraria islandica and Pseudevernia furfuracae to avoid detrimental effects on multiple tissues of rats. 
Diabetes mellitus (DM) with the subsequent generation of oxidative stress represents a major risk factor for organs. The second aim of this 
study is to investigate whether administration of both lichens could prevent type 1 diabetes (T1D)-induced organ dysfunctions. During two 
weeks, both control and diabetic rats were treated with aqueous lichen extracts. The metabolic changes were determined. On day 14, after 
animals were decapitated, required samples for biochemical and genetic analysis were collected. Oxidative damage of DNA was estimated by 
measuring the increase in 8-hydroxy-2’-deoxyguanosine formation. Biochemical parameters were used to observe and evaluate the functional 
changes in tissues. Experimental data showed that the increasing doses of lichens alone have not any detrimental effect on above parameters. 
Moreover, C. islandica decreased the diabetes-induced glucose and malondialdehyde (MDA) levels. Thus, it seemed that the antioxidant 
treatment has an important effect on the organ failure in ill rats. However, the protective effect of C. islandica was inadequate on diabetes-
induced disorders and DNA damages. Lichens are a safe in the studied dose range but the power of C. islandica is limited because of intensive 
oxidative stress in essential organs of T1D rats.
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      8-hydroxy-2’-deoxyguanosine
Liken Ekstrelerinin Sağlıklı Ratlar Üzerindeki Etkileri ve 
Bu Ekstrelerin Diyabete Bağlı Çoklu Organ Yetmezliğinin 
Önlenmesinde Medikal Kullanımı
Özet
Bu çalışmada, ilk olarak Cetraria islandica ve Pseudevernia furfuracae türü liken ekstraktlarının sıçanlara ait çeşitli dokular üzerine zararlı 
etkilerinin olup olmadığı değerlendirilmiştir. Diabetes mellitusa (DM) bağlı oksidatif stres, organlar için büyük bir risk faktörü oluşturmaktadır. 
Çalışmamızın ikinci bölümünde ise her iki liken ekstaktı uygulamasının tip 1 diyabet kaynaklı organ bozukluklarına karşı koruyucu olup 
olmadıklarını araştırılmıştır. İki hafta boyunca hem kontrol hem de diyabetli ratlara sulu liken ekstreleri uygulanmıştır. Süre sonunda 
metabolik değişimler belirlenmiştir. Ondördüncü günde, hayvanların yaşamları servikal dislokasyonla sonlandırıldıktan sonra biyokimya ve 
genetik çalışmalar için gerekli örnekler alınmıştır. DNA’nın oksidatif hasarı 8-hidroksi-2’-deoksiguanosin oluşumunda meydana gelen artış 
ölçülerek hesaplanmıştır. Biyokimyasal parametreler dokularda meydana gelen fonksiyon değişimlerinin gözlenmesi ve değerlendirilmesi 
için kullanılmıştır. Deney sonuçları tek başına uygulanan liken ekstraktlarının artan dozlarda herhangi bir zararlı etkiye sahip olmadığını 
göstermiştir. Ayrıca, C. islandica diyabete bağlı artan kan glikoz ve malondialdehit (MDA) seviyesini kısmen düşürmüştür. Antioksidan tedavinin 
hasta ratlarda organ yetmezliğine karşı fayda sağlayacağı düşünülmektedir. Bununla birlikte, C. islandica’nın antioksidan etkisinin diyabet 
teşvikli bozukluklarda ve DNA hasarına karşı yetersiz olduğu anlaşılmıştır. Sonuç olarak, likenlerin çalışılan doz aralığında güvenli olduğu ve tip 
1 diyabetin neden olduğu yaşamsal organlar üzerindeki güçlü oksidatif stres nedeniyle C. islandica sınırlı bir etkiye sahip olduğu gözlenmiştir. 
Anahtar sözcükler: Cetraria islandica, Pseudevernia furfuracae, Diyabetes mellitus, Organ bozuklukları,  
      Antioksidan kapasite, 8-hidroksi-2’-deoksiguanosin
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INTRODUCTION
DM is one of the most common endocrine metabolic 
disorders in developing countries. T1D affects millions of 
people worldwide and has an incidence that is increasing 
at a striking rate, especially in young children [1]. A large 
body of earlier investigations has examined the role 
of oxidative stress in insulin resistance in type 1 and 
type 2 diabetes and its associated complications [2]. The 
investigations have revealed that hyperglycemia degrades 
antioxidant enzyme defenses by allowing reactive oxygen 
species to damage cells and tissues [3]. The balance of 
glucose by the drugs has emerged as a novel therapeutic 
approach to disease that develop with high circulating 
glucose. Lichens have been used for various purposes 
such as dyes, perfumes and remedies in folk medicine 
indicating the pharmaceutical potential of lichens [4]. The 
lichens have also antioxidant, antimicrobial and anticancer 
properties [5,6]. It is documented that they effective in the 
treatment of tuberculosis [7], hemorrhoids and dysentery [8] 
and also induce apoptosis in colon [9,10] and prostate 
cancers [11]. Lichen species are very common in Turkey. 
Unique lichen flora has attracted many researchers on 
the systematical basis [12]. It is pointed that lichens may be 
easily accessible sources of natural drugs that could be 
used as a possible food supplement or in pharmaceutical 
industry [13].
Diabetic nephropathy (DN) remains the most common 
cause of end-stage renal disease [14]. Chronic kidney disease 
(CKD) is characterized by progressive decline in renal 
function [15]. To prevent the development of this disease and 
to improve advanced kidney injury, effective therapies are 
required. Although diabetic hepatopathy is potentially less 
common, it may be appropriate for addition to the list of 
target organ conditions related to diabetes [16]. Enzymology 
is a diagnostic indicator for diabetes in liver dysfunctions. 
Therefore, liver function tests (LFTs) are commonly used in 
clinical practice to screen the progression of disease, and 
monitor the effects of hepatic drugs. The most common 
LFTs include the serum aminotransferases as aspartate 
aminotransferase (AST) and alanine aminotransferase 
(ALT) and lactate dehydrogenase (LDH). A rational therapy 
rich in antioxidants reduces levels of metabolical disorders 
in diabetic individuals [17]. Here we used a strategy based 
on feasible alternative therapeutic for metabolically labile 
patients with T1D. So far, lichens have not been evaluated 
under controlled conditions suggesting improved glucose 
control and a reduced risk of hypoglycemia. This opens 
up an important strategy for therapy of diabetes and 
may provide a promising avenue for future approaches 
to lichens. In response to pharmacological activation or 
oxidative stress, we studied two well-known lichen species 
Cetraria islandica (C. islandica), Pseudevernia furfuracea 
(P. furfuracea) in relation to the survival of liver, pancreas 
and kidney in model with T1D. In many countries, C. 
islandica is used medicinally e.g. for colds, bronchitis, 
and asthma [18] and P. furfuracea is studied for antioxidant 
properties in vitro conditions [19].
Although these lichens are popular around the world, 
their beneficial and/or adverse effects on human health 
have not been scientifically determined yet. Hence, our 
study firstly assessed C. islandica and P. furfuracea extracts 
to avoid detrimental effects on multiple tissues of rats in 
vivo conditions. Secondly, the aim of present study was to 
evaluate the effects of C. islandica and P. furfuracea on the 
development of diabetes-related organ dysfunctions, in 
relation to biochemical changes and also DNA damages in 
diabetic rats. The correlation of DNA damage with adverse 
health effects is important in evaluating the safety of various 
agents and prospective therapeutics. Many techniques 
exist that afford the ability to identify and measure cellular 
DNA damage upon exposure to a suspected genotoxic 
agent; however, the modified nucleoside 8-hydroxy-2’-
deoxyguanosine (8-OHdG) is commonly used as a reliable 
and sensitive index of oxidative DNA damage [20].
There is a very little information regarding the 
biological activity of these two lichen species. Therefore, in 
this study, the effects of two lichen species at the different 
doses (250 and 500 mg/kg bw) were investigated in 
non-diabetic, diabetic and lichen-treated diabetic rats.
MATERIAL and METHODS
Lichen Extracts
Lichen species, C. islandica (L.) Ach. and P. furfuracea (L.) 
Zopf were collected from the Giresun, Erzurum and Artvin 
province in Turkey, during summer of 2011. The samples 
were identified using various flora books and papers [12,21]. 
Identified samples were air-dried and stored in the 
herbarium of Kazım Karabekir Education Faculty, Atatürk 
University. For water extraction of lichenes, 20 g sample 
was mixed with 400 mL distillated and boiling water using 
magnetic stirrer for 15 min. Then the extracts were filtered 
over Whatmann No. 1 paper. The filtrates were frozen and 
lyophilized in lyophilizator (Labconco, Freezone IL) [19]. 
Animals
Seventy adult male Spraque-Dawley rats (6 weeks old, 
weighing 200-250 g) obtained from Medical Experimental 
Application and Research Center, Atatürk University were 
used. Animals were housed inside polycarbonate cages 
in an air-conditioned room (22±2°C) with 12-h light-
dark cycle. Standard rat feed and water were provided 
ad libitum. The rats were allowed to acclimatize to the 
laboratory environment for 7 days before the start of the 
experiment. All procedures were performed in conformity 
with the Institutional Ethical Committee for Animal Care 
and Use at Atatürk University (Protocol Number: ATADEM, 
B.30.2.ATA.0.23.85-11 and Date: 26.03.2010) and the Guide 
for the Care and Use of Laboratory Animal. 
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Experimental Induction of Diabetes
Streptozotocin (STZ) (single dose of 50 mg/kg bw) 
(purchased from Sigma, St Louis, MO, USA) dissolved in 
freshly prepared 0.01 M citrate buffer pH 4.5 was injected 
intraperitoneally in a volume of 1 ml/kg. STZ-induced 
animals exhibited massive glycosuria and hyperglycemia 
within 2 days. T1D was confirmed in STZ-induced rats by 
measuring the fasting blood glucose concentration 72 
h after the injection of STZ. The rats with blood glucose 
level>200 mg/dl were considered to be diabetic and were 
used in the experiment [22].
Experimental Design
There was very little evidence in the literature about 
lichens and their uses on therapy and therefore the study 
included from 5 to 500 mg/kg large-dose range. Use of 
large-dose range of lichens provided a more convenient 
and potentially more effective strategy for assisting 
diabetic recovery. The effective doses were 250 and 500 
mg/kg and thus the rats were randomly divided into ten 
groups (n=7) as follows (Table 1):
The aqueous extracts of lichens were administered 
intraperitoneally daily for 14 days. After completion of the 
experiments, rats were killed via rapid decapitation without 
anaesthetic. The body weight, feed, and water intake in 
animals were measured. The blood and tissue samples 
of rats were collected for biochemical and oxidative DNA 
damage analyses.
Biochemical Analyses
The blood glucose levels were measured with a 
automatic glucometer (Accu-Chek GO®) in a tail blood 
before decapitation. The rat serum insulin levels were 
detected by commercial elisa kit purchased from Randox 
Laboratories Ltd Dialab Produktion und laborinstriementen 
Gessellschaftm.b.H. (A-1160 Wien-panikengasse, Germany). 
The serum samples were prepared by centrifugation 
at 1.600 g at 4°C for 15 min using a cooling centrifuge 
(Nüve, NF 400R, Turkey). The blood glucose and serum 
insulin levels were respectively expressed in mg/dL 
and µg/L.
Blood samples were collected into serum superetor 
tubes (Microtainer; Becton Dickinson, Franklin Lakes, NJ, 
USA), allowed to stand (75-90 min), centrifuged (11.000 
g, 5 min), serum harvested, and stored at -20°C. The 
following parameters for liver injury were measured by 
an automated biochemical analyzer (OLYMPUS AU 2700) 
with Bayer testing kits (Bioclinica): AST, ALT and LDH. 
Renal impairment was assessed by blood urea nitrogen 
(BUN) and serum creatinine (Cr) and uric acid (UA) levels 
with an autoanalyzer (Syncron LX 20, Galway, Ireland) by 
using commercial Beckman Coulter diagnostic kits. After 
the 14 day treatment, the rats were fasted overnight and 
then decapitated. Thoracic cavities were incised open; 
pancreas, liver, and kidney tissues were removed and 
stored at −70°C. All defrosted tissues were homogenized 
in ice shower containing 4 mL of 0.2 M phosphate buffer 
at pH 7.4. Homogenates were centrifuged at 3.000 g for 
15 min at 4°C to remove tissue remnants. Activities were 
determined in the supernatant. Total antioxidant capacity 
(TAC) levels were measured using the commercial kit 
(Rel Assay Diagnostic) Syncron LX autoanalyzer [23] Lipid 
peroxidation was determined by quantifying malondi-
aldehyde (MDA) concentrations, which was spectro-
photometrically measured by the absorbance of a red-
colored product with thiobarbituric acid [24].
Nucleic Acid Oxidation
DNA was extracted from 100 mg tissue samples by 
commercially available DNA extraction kits (DNAzol® Life 
Technologies, Gaithersburg, MD, USA). Via using these 
kits up to approximately 5 μg of DNA/mg of tissue was 
obtained. Extracted DNA was dissolved in water at 1-5 mg/
mL. Then DNA samples were converted to single-stranded 
DNA by incubating the sample at 95°C for 5 min and rapidly 
chilling on ice, and digested to nucleosides by incubating 
the denatured DNA with 5-20 units of nuclease P1 for 2 h 
at 37°C in 20 mM sodium acetate, pH 5.2, and following 
with treatment of 5-10 units of alkaline phosphatase 
Table 1. Experimental groups
Tablo 1. Deney grupları
Non-diabetic 
Non-diabetic control Group 1 (NC): Non-diabetic control rats (n=7)
Treated with CIAE
Group 3 (CIAE-250): Rats recevied 250 mg/kg bw aqueous extract of Cetraria islandica (n=7)
Group 4 (CIAE-500): Rats recevied 500 mg/kg bw aqueous extract of Cetraria islandica (n=7)
Treated with PFAE
Group 5 (PFAE-250): Rats recevied 250 mg/kg bw aqueous extract of Pseudevernia furfuracea (n=7)
Group 6 (PFAE-500): Rats recevied 500 mg/kg bw aqueous extract of Pseudevernia furfuracea (n=7)
Diabetic 
Diabetic control Group 2 (DC): Diabetic control rats recevied 50 mg/kg bw single injection (ip) of STZ (n=7)
Treated with CIAE
Group 7 (CIAE-250): Diabetic rats treated with 250 mg/kg bw aqueous extract of Cetraria islandica (n=7)
Group 8 (CIAE-500): Diabetic rats treated with 500 mg/kg bw aqueous extract of Cetraria islandica (n=7)
Treated with PFAE
Group 9 (PFAE-250): Diabetic rats treated with 250 mg/kg bw aqueous extract of Pseudevernia furfuracea (n=7)
Group 10 (PFAE-500): Diabetic rats treated with 500 mg/kg bw aqueous extract of Pseudevernia furfuracea (n=7)
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for 1 h at 37°C in 100 mM Tris, pH 7.5 [25]. The levels of 
8-OHG in the samples were then quantiated using a HPLC 
technique with electrochemical detection (HPLC-EC) by 
an adaptation of the method of Kasai et al.[26] as described 
previously [27]. Briefly we used Kontron HPLC pump for 
420 as HPLC apparatus, Beckman ultrasphere (0.46 x 25 
cm) as column, and 8% aqueous methanol containing 10 
mM NaH2PO4 as eluent, the flow rate was 1 ml/min. Peaks 
gained with electrochemical (for 8-OHdG) and UV (for 
dO) detectors were integrated under a background noise 
corection loaded on an integrator. The levels of 8-OHdG 
were determined as numbers of 8-OHdGs per l06 dOs, by 
calibration against curves from runs of standard samples, 
containing known amounts of authentic 8-OHdG and dG. 
During the asays, light and air contamination were avoided 
as strictly as posible.
Statistical Analysis
For statistical analysis, we used SPSS for Windows 13.0 
(SPSS Inc., Chicago, USA). The experimental data were 
analysed using oneway analysis of variance (ANOVA) 
followed by Tukey post hoc test for multiple comparisons. 
Results are presented as mean ± standart deviation 
(SD) and values P<0.05 were regarded as statistifically 
significant.
RESULTS
The diagnostic parameters of both control and 
experimental rats before and after 14 days of treatment 
with STZ are shown in Fig. 1 and Fig. 2. According to figures, 
the feed and water intake in diabetic rats are significantly 
increased throughout the study period as compared with 
the normal control group. Intraperitoneal administration 
of two lichen species extracts with low doses did not 
have a positive effect on diagnostic and body weight 
compared with diabetic rats. Moreover, similar results were 
also observed with higher doses administration of lichen 
extracts (data not shown). Conversely, the weight loss of ill 
animals is prominent. 
In addition, intraperitoneal administration of STZ 
into the rats causes significant diabetogenic response 
in subjects with significant increase in the level of blood 
sugar and a significant decrease in the level of insulin as 
compared with normal rats (Fig. 3 and Fig. 4). The blood 
glucose level is increased from an avarage 100 mg/dL to 
about 450 mg/dL. And the insulin level is decreased to 4 
µg/L from 9 µg/L. Following intraperitoneal injection of 
C. islandica and P. furfuracea extracts, the feed and water 
intake are not changed as compared with the diabetic 
untreated rats. Furthermore, the extracts alone have not 
any adverse effect the body weight of the animals, blood 
glucose and insulin levels (data not shown). In animals 
with T1D, the treatment with C. islandica does not show 
positive effect on above parameters except for glucose 
and insulin levels. It is established that the administration 
of lichen at the dose 250 mg/kg, the blood glucose reduces 
and insulin levels increases as compared with diabetic rats 
(P>0.05). Depending on the increasing dose, the responses 
are not enhanced and such changes go unnoticed in T1D 
rats. Unfortunately, above parameteres remain unchange 
with respect to 250 mg/kg dose of P. furfuracea in 
diabetic animals and also both lichen extracts do not 
show any evidence of dose-related effect. Often such 
change goes unnoticed in pictures, although it can affect 
preference.
Table 2 shows the effects of C. islandica and P. furfuracea 
on biochemical parameters in all experimental groups. As 
compared with the controls, the TAC level are markedly 
decreased in pancreas, kidney and liver of diabetic rats 
Fig 1. The effect of aqueous extracts of C. islandica (CIAE) and P. furfuracea (PFAE) on feed and water 
intake in control and diabetic rats (n=7); NC: Non-diabetic control group, DC: Diabetic control group, 
D+CIAE: Diabetic rats treated with C. islandica aqueous extract (250 or 500 mg/kg) and D+PFAE: 
Diabetic rats treated with P. furfuracea aqueous extract (250 or 500 mg/kg)
Şekil 1. Kontrol ve diyabetik sıçanlarda yem ve su alımı üzerindeki C. islandica (CIAE) ve P. furfuracea 
(PFAE) sulu ekstraklarının etkisi (n=7); NC: Non-diyabetik kontrol grubu, DC: Diyabetik kontrol 
grubu, D+CIAE: C. islandica sulu ekstresi ile tedavi edilen diyabetik sıçanlar (250 veya 500 mg/kg) ve 
D+PFAE islandica: P. furfuracea sulu ekstresi ile tedavi edilen diyabetik sıçanlar (250 veya 500 mg/kg)
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while MDA increased (P<0.05). In alone lichen treatments, 
MDA levels remain unchanged and lichens do not show 
any adverse effect with respect to increasing dose. 
Furthermore, the P. furfuracea extract increases the level 
of TAC at both dosage (250 and 500 mg/kg) but the best 
result is observed at the doses of C. islandica. However, the 
increase of TAC after supplementation with C. islandica is 
inadequate STZ-induced diabetic groups and MDA levels 
does not return to the control values (P>0.05). Moreover, 
the effect of extracts on these parameters is not dose 
related (data not shown). 
In the rat kidney tissues, the levels of BUN and UA 
decrease in the C. islandica 250 and C. islandica 500 mg/kg 
groups when compared with the T1D (Table 3); however, 
statistically significant differences were not seen between 
these groups and the control groups (P>0.05). Serum Cr 
is not reduced in T1D+C. islandica and T1D+P. furfuracea 
groups, whereas, all parameters are similar in experimental 
rats with C. islandica and P. furfuracea alone to controls.
In present study, activity levels of serum marker 
enzymes of liver are found elevated markedly in rats with 
T1D (Table 4). No such changes are observed in control 
rat samples. As is evident from table, lichen doses alone 
(250 and 500 mg/kg) are not change the activity levels 
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Fig 2. The effect of aqueous extracts of C. 
islandica (CIAE) and P. furfuracea (PFAE) on 
body weight in control and diabetic rats (n=7)
Şekil 2. C. islandica (CIAE) ve P. furfuracea 
(PFAE) sulu ekstraktlarının kontrol ve diyabetik 
sıçanların vücut ağırlığına etkisi (n=7)
Fig 3. The effect of aqueous extracts of C. 
islandica (CIAE) and P. furfuracea (PFAE) on 
blood glucose level in control and diabetic 
rats (n=7); Data are mean±SD values (n=7). 
They are significantly different between aNC 
and bDC group. (P>0.05; Tukey’s multiple 
range test)
Şekil 3. C. islandica (CIAE) and P. furfuracea 
(PFAE) sıvı ekstraktlarının kontrol ve diya-
betik sıçanların kan glukoz seviyesine etkisi 
(n=7); Veriler ort±SD değerlerdir (n=7). aNC 
ve bDC gruplar arasında anlamlı bir farklılık 
vardır. (P>0.05; Tukey çoklu karşılaştırma testi)
Fig 4. The effect of C. islandica (CIAE) and P. furfuracea (PFAE) extracts on serum insulin level in control 
and diabetic rats (n=7); Data are mean±SD values (n=7). They are significantly different between aNC 
and bDC group. (P > 0.05; Tukey’s multiple range test)
Şekil 4. C. islandica (CIAE) and P. furfuracea (PFAE) ekstraktlarının kontrol ve diyabetik sıçanların serum 
insulin seviyelerine etkisi (n=7); Veriler ort±SD değerlerdir (n=7). aNC ve bDC gruplar arasında anlamlı bir 
farklılık vardır. (P> 0.05; Tukey çoklu karşılaştırma testi)
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of AST, ALT and LDH (P>0.05). And the treatment with 
C. islandica can bring a decrease in the activity levels of 
these enzymes when compared to P. furfuracea group. 
Our results clearly reveal that C. islandica presents positive 
effects on the activities of enzymes without undepending 
on dose against T1D-induced liver damages. However, the 
levels of all ALT and AST enzyme samples do not show a 
significant similarity with control values after treatments 
with C. islandica in T1D. Moreover, the LDH enzyme activity 
is not normalized by doses of C. islandica exposure. 
The status of 8-hydroxy-2’-deoxyguanosine (8-OHdG) 
in studied tissues of control and experimental groups is 
presented in Fig. 5. Compared with the control group, there 
are significant increases in hepatic, kidney and pancreatic 
8-OHdG levels in STZ-induced diabetic rats (P<0.05). 
Whereas, all doses of C. islandica and P. furfuracae extracts 
alone have not any effect on the level of 8-OHdG. However, 
post-treatment of C. islandica extracts can’t significantly 
restore the oxidative DNA damage in the multiple tissues 
of diabetic rats without undepending on dose. 
DISCUSSION
Increased throughput of any substrate involves 
a regional imbalance between ROS production and 
breakdown. Oxidative stress is a consequence of high 
circulating glucose levels in diabetic patients and rodents. 
Furthermore, a change in the balance of glucose substrate 
entails a degree of cellular oxidative stress [28]. In present 
study we assessed indicator of oxidative stress, MDA, in 
Table 2. The effect of C. islandica (CIAE) and P. furfuracea (PFAE) extracts on MDA and TAC levels in pancreas, kidney and liver tissues in normal and  
diabetic rats








Pancreas Liver Kidney Pancreas Liver Kidney
Normal 4.33±0.97a 3.46±0.43a 6.61±0.32a 1.51±0.12d 1.81±0.76d 1.63±0.3d
Diabetic control 9.62±1.01b 8.02±0.85b 13.79±1.06b 0.79±0.17f 1.07±0.11f 0.94±0.13f
CIAE (250) 4.17±0.66a 3.04±0.69a 6.23±0.73a 1.95±0.16a 2.23±0.31a 2.14±0.49a
CIAE (500) 4.26±1.09a 3.28±0.29a 6.36±0.44a 1.79±0.29b 2.11±0.17b 1.97±0.29b
PFAE (250) 4.36±0.59a 3.35±0.21a 6.47±0.81a 1.71±0.19b,c 2.04±0.22b,c 1.87±0.34b,c
PFAE (500) 4.42±0.78a 3.51±0.75a 6.58±0.37a 1.63±0.28c 1.96±0.46c 1.79±0.26c
Diabetic+ CIAE(250) 9.17±0.85b 7.65±0.39b 13.39±1.52b 0.99±0.37e,f 1.26±0.43e,f 1.13±0.33e,f
Diabetic+ CIAE(500) 9.55±1.02b 7.93±0.46b 13.72±1.64b 0.83±0.32f 1.12±0.25f 1.0±0.28f
Diabetic+ PFAE(250) 9.59±0.88b 7.98±0.37b 13.76±1.73b 0.81±0.14f 1.11±0.21f 0.98±0.13f
Diabetic+ PFAE(500) 9.60±1.06b 8.01±0.54b 13.78±1.41b 0.80±0.24f 1.08±0.39f 0.95±0.19f
YValues are mean±SD of seven rats in each group (n=7). Means of five measurements marked by different letters within each column present a statistical 
difference at P<0.05 CIAE: C. islandica aqueous extract (250 or 500 mg/kg) and PFAE: P. furfuracea aqueous extract (250 or 500 mg/kg)
Table 3.The effect of C. islandica (CIAE) and P. furfuracea (PFAE) extracts on serum BUN, UA and Cr levels in normal and diabetic rats
Table 3. Kontrol ve diyabetik ratlarda serum BUN, UA ve Cr seviyeleri üzerine C. islandica (CIAE) ve P. furfuracea (PFAE) ekstraktlarının etkisi
GroupsY BUN (U/L) UA (U/L) CRE (U/L)
Normal 24.67±3.54 1.35±0.13 0.37±0.04
Diabetic control 91.11±9.17a 3.87±0.89a 0.84±0.08a
CIAE (250 mg/kg) 23.94±4.15b 1.17±0.54b 0.48±0.05b
CIAE (500 mg/kg) 24.60±2.42b 1.42±0.61b 0.39±0.02b
PFAE (250 mg/kg) 24.43±5.01b 1.21±0.49b 0.34±0.01b
PFAE (500 mg/kg) 23.27±7.16b 1.33±0.44b 0.36±0.02b
Diabetic+ CIAE (250 mg/kg) 86.41±6.94a 3.22±0.21a 0.79±0.06a
Diabetic+ CIAE (500 mg/kg) 90.17±6.82a 3.79±0.38a 0.81±0.07a
Diabetic+ PFAE (250 mg/kg) 91.56±7.01a 3.85±0.29a 0.82±0.08a
Diabetic+ PFAE (500 mg/kg) 91.87±5.37a 3.91±0.41a 0.85±0.07a
YValues are mean±SD of seven rats in each group (n=7). aSignificant difference was detected in experimental groups comparing with normal group at 
P<0.05. bSignificant difference was detected in experimental groups comparing with diabetic control group at P<0.05
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pancreas, kidney and liver cells. MDA is an important by-
product of lipid peroxidation (LPO), and therefore high 
levels of MDA lead to oxidative damage to cell membrane 
lipids [29]. Regrettably, the results presented in this work 
showed that high glucose allowed the production of MDA 
effectively in multiple tissues of diabetic rats. It is reported 
that oxidative stress is a major mediator of tissue and 
cell injuries [30]. Hence, in vivo risk assessment for lichens 
needs exploration. This study assesses the oxidative effects 
of C. islandica and P. furfuracea extracts on pancreas, 
liver and kidney tissues of rats. Fortunately, MDA levels 
remained unchanged and lichens alone did not show any 
adverse effect with respect to increasing dose. Targets of 
accumulating ROS include proteins involved in antioxidant 
response. Thus, there is accumulating evidence that 
interaction of the antioxidant defense system as a regulator 
of disease development and oxidative stress generation 
in diabetic patients evokes diabetic organ complications, 
liver and kidney dysfunctions, and pancreatic β-cell 
apoptosis [30,31]. These organs contain a number of 
endogenous antioxidants, to restrict steady state ROS 
levels. The balance between ROS generation and their 
elimination by endogenous antioxidant mechanisms play 
a critical role in preserving organ functions; inappropriate 
levels of ROS likely precipitate impairment of functions 
and abnormalities in organ structure [32]. A variety of natural 
antioxidants exists to scavenge oxygen free radicals and 
prevents oxidative damage to biological structures. The 
natural products have antioxidant potential to protect the 
essential organs against the oxidative damage induced by 
diabetes [33]. Nowadays, lichens as a novel bioresource for 
natural antioxidant have been discovered [34]. P. furfuracea 
is shown to modulate the adverse effects of AFB(1) in 
human blood cells [19]. The antioxidant properties of C. 
islandica and P. furfuracea are explained in vitro [5,6,19], but 
not in vivo. Our results corroborate this antioxidant activity 
of lichens and extracts have attractive properties with 
increasing TAC levels in pancreas, liver and kidney tissues 
in vivo. In these tissues, C. islandica significantly increased 
TAC level and P. furfuracea presented moderate antioxidant 
supplement for tissues. TAC combines the activities of 
non-enzymes such as glutathione (GSH) and enzymes 
such as superoxide dismutase (SOD), catalase (CAT), and 
glutathione peroxidase (GSH-Px) [35,36]. The most abundant 
intracellular antioxidant, GSH, lowers endogenous ROS 
and/or exogenous oxidative damage in animal cells 
GSH-Px enzyme metabolises peroxides such as H2O2 and 
protects cell membranes from LPO [37]. According to Ralph 
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Table 4. The effect of C. islandica (CIAE) and P. furfuracea (PFAE) extracts on serum AST, ALT and LDH levels in control and diabetic rats
Tablo 4. Kontrol ve diyabetik ratlarda serum AST, ALT ve LDH seviyeleri üzerine C. islandica (CIAE) ve P. furfuracea (PFAE) ekstraktlarının etkisi
GroupsY AST (U/L) ALT (U/L) LDH (U/L)
Normal 167±26.57 51.15±6.27 1335.21±134.76
Diabetic control 371.1±43.63a 82.91±4.72a 2069.48±204.11a
CIAE (250 mg/kg) 172.9±24.71b 51.19±3.94b 1305.56±153.45b
CIAE (500 mg/kg) 174.3±27.91b 54.39±2.99b 1349.35±126.24b
PFAE (250 mg/kg) 169.7±35.07b 53.25±5.17b 1363.40±143.46b
PFAE (500 mg/kg) 170.5±24.03b 51.72±4.62b 1427.72±137.08b
Diabetic + CIAE (250 mg/kg) 316.4±36.24a 75.87±3.66a 1995.87±171.49a
Diabetic + CIAE (500 mg/kg) 341.7±48.91a 79.30±4.01a 2027.19±185.53a
Diabetic + PFAE (250 mg/kg) 360.2±34.27a 81.48±3.87a 1994.21±194.34a
Diabetic + PFAE (500 mg/kg) 368.4±29.06a 83.55±3.21a 2097.71±49.37a
YValues are mean±SD of seven rats in each group (n=7). aSignificant difference was detected in experimental groups comparing with normal group at 
P<0.05. bSignificant difference was detected in experimental groups comparing with diabetic control group at P<0.05
Fig 5. The effect of C. islandica (CIAE) and P. 
furfuracea (PFAE) extracts on 8-OHdG levels 
on liver, kidney and pancreas tissues in 
normal and diabetic rats (n=7); The symbols 
used for different tissues indicate the groups 
that are significantly difference from control 
group 
Şekil 5. C. islandica (CIAE) ve P. furfuracea 
(PFAE) ekstraktlarının, normal ve diyabetik 
sıçanların karaciğer, böbrek ve pankreas 
dokularında 8-OHdG düzeyleri (n=7); Farklı 
dokular için kullanılan simgeler, kontrol 
grubu ile karşılaştırıldığında anlamlı olan 
grupları temsil eder
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et al.[38], amino acids may protect against toxicity by serving 
as precursors for GSH. GSH becomes depleted if cells are 
deprived of energy substrates. In a hepatopathy model, the 
effects of C. islandica extract are carried out on rats, treated 
intraperitoneally. It is reported that C. islandica extract has 
hepatoprotective and immuno-stimulating effects [39,40]. 
C. islandica determined adaptogenic-antistress effects, 
confirmes by its actions on oxidative stress parameters [40]. 
In this study, C. islandica and P. furfuracea might be a 
promising treatment in rats with T1D. Thus, lichen-based 
therapy is firstly used by this investigastion in treatment 
of T1D. The results of this study clearly demonstrated that 
STZ caused significant increases MDA levels in multiple 
tissues. Conversely, TAC levels in T1D rats were much lower 
than those healthy controls (P<0.05). It was crucial that our 
research focus on the high antioxidant ability of C. islandica 
for adequate treatment of tissues. After supplementation 
with C. islandica in diabetic animals, decreased in MDA 
levels and increased in TAC levels were found but the 
in vivo activation of antioxidant capacity by this lichen 
produced a limited and slight prevention of the tissue cell 
destructions. The antioxidant status after the P. furfuracea 
treatment was measured to evaluate the effectiveness of a 
therapy and unfortunately was not improved the clinical 
response. Again, it was established that there was not any 
an association between increasing lichen doses and above 
parameters. As a matter of fact, the high dose of lichens 
did not allow for a better evaluation of therapeutic effect 
because of their unchanged antioxidant properties. 
The anti-diabetic extracts induce important metabolic 
changes in T1D [41]. Carbohydrate metabolism disorders 
in the form of T1D connect with an process connected 
with the increase of the insulin [42]. And the strict control 
of the blood glucose level is considered to be essential 
in order to delay and/or prevent the development of 
diabetic complications [42]. In this study, we investigated 
the responses elicited by lichens and how these responses 
may regulate T1D development. The experimental data 
showed that P. furfuracea lichen did not positively affected 
plasma insulin level and C. islandica extract (250-500 mg/
kg) did not provide a significant advantage for T1D rats. 
Therefore, increase in blood glucose level unfortunately 
was not inhibited after administration of C. islandica. On 
the other hand, the most significant markers of T1D in 
both human and animal models are polydypsia and poly- 
phagia [43]. As compared with the normal rats, we determined 
that the feed and water intake of the diabetic rats were 
significantly increased. Additionally, the insulin-induced 
the weight loss was observed after induction of STZ into 
the animals in present investigation. Animals treated 
with STZ exhibite continuous hyperglycemia, which 
coincided with a nearly complete loss of islet β-cells [44,45].
Two explanations for weight loss may be presented; firstly, 
due to polyuria and dehydration the body weight may be 
declined and, secondly, as the blood glucose level is high 
there is possibility of muscle breakdown in hyperglycemic 
rats [46]. Only, the treatment with the C. islandica enhanced 
pancreas function by improving glucose tolerance and 
increasing β-cell insulin reserve in rats. However, C. 
islandica seemed inadequate to prevent body weight loss 
in diabetic rats.
In current study, diabetic rats presented renal damages 
that were evidenced by the elevation in serum urea, uric 
acid, and creatinine levels, which were considered as 
significant markers of renal dysfunction [47]. Further our 
findings, it has been found that the liver was necrotized 
in diabetic rats due to the deficiency of insulin because of 
pancreas dysfunction. It is reported that insulin suppress 
the gene encoding gluconeogenic enzymes [48], ALT is a 
gluconeogenic enzyme and it is an indicator of impaired 
insulin signaling [49]. In present study, the activity of AST also 
increased in diabetic rats, this could be due to an increased 
release oxidative insult of diabetes lead to damage in 
hepatocytes [50]. Again, the LDH in serum as a biological 
marker for liver damage increases [51]. Cell necrosis leads 
to a rise in the concentration of the LDH enzyme in serum 
and tissue. The LDH released into the medium provides 
an index of cell death and membrane permeability to LDH, 
and an increase in LDH activity in the medium occurs as 
a result of cell membrane disintegration and enzyme 
leakage [52]. Thus, the increased activities of ALT, AST and 
LDH in serum is mainly due to the leakage of these enzymes 
largely from the liver cytosol into the blood stream [53], 
which gives an indication of the abnormal function of liver. 
This study also revealed that hepatocytes retained their 
capacity to normal function after lichen alone exposures. 
Moreover, C. islandica against T1D presented useful effects 
on the activities of enzymes without undepending on 
dose (ALT and AST except for LDH).
The renal impairment, hepatic and pancreatic damage 
in T1D may be associated with a number of genetic 
disorders [54]. The method used in the present study is 
8-OHdG, which is known to be a sensitive marker of 
oxidative DNA damage and of the total systemic oxidative 
stress in vivo [55]. 8-OHdG is a product of oxidative DNA 
damage following specific enzymatic cleavage after the 
ROS-induced 8-hydroxylation of guanine bases in DNA [56]. 
Importantly, 8-OHdG appears to play a role in tissue cell 
injury via the induction of apoptotic cell death [57]. Levels of 
8-OHdG have been found to be increased in the pancreatic 
β cells of STZ-diabetic rats [58,59]. Similarly, increased number 
of 8-OHdG–positive islet cells was found in our study.  In 
addition, our data confirmed a previous report of the 
accumulation of 8-OHdG in the nuclear DNA in kidney and 
liver of diabetic rats. 8-OHdG levels are rapidly normalized 
by insulin treatment, suggesting the involvement of 
hyperglycemia in oxidative DNA damage [57-59]. In this 
study, we provided evidence that lichen extracts alone did 
not show the production of 8-OHdG during exposure. We 
also demonstrated that 8-OHdG accumulation in multiple 
tissues was reduced by the C. islandica on the association 
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between the glycaemic control and levels of 8-OHdG. 
This is in agreement with a recent study showing that 
treatment of rat tissues with antioxidants reverse glucose-
mediated ROS production [60,61]. Thus, the measurement of 
8-OHdG has been associated with potential antioxidant 
capacity of C. islandica. 
To our knowledge, this report provides the first account 
of the C. islandica and P. furfuracea extracts in vivo. The 
increasing supplement of C. islandica and P. furfuracea 
alone do not show any oxidative and genotoxic effect in 
pancreas, kidney and liver of diabetic animals. Our opinion: 
these lichen species are a safe and findings also offer the 
possibility to early intervene in risk reduction of T1D by 
using C. islandica. As amatter of fact, C. islandica improve 
antioxidant defense system and presents anti-genotoxic 
effects but the power of C. islandica is limited because of 
intensive oxidative stress in multiple organs of T1D rats.
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